Brian Joseph Hoff - 24 Jul 2026 Form 4 Insider Report for Unusual Machines, Inc. (UMAC)

Reporting relationship: Chief Financial Officer
Issuer ticker: UMAC
Reported as of: 24 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jul 2026, 16:10:29 UTC
Prior SEC filing: 29 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian Hoff

Key filing fact

Brian Joseph Hoff filed Form 4 for Unusual Machines, Inc. (UMAC) on 28 Jul 2026.

Key facts

This page summarizes Brian Joseph Hoff's Form 4 filing for Unusual Machines, Inc. (UMAC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Jul 2026, 16:10.

Change

Previous filing in this sequence was filed on 29 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856726 Primary reporting owner

Hoff Brian Joseph

Relationship: Chief Financial Officer
Address: 5728 MAJOR BLVD, STE #250, ORLANDO
Signature: /s/ Brian Hoff
Signature date: 28 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UMAC transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
Shares: +375,000
Change %
Price: $0.000000^*
Shares after: 375,000
Date: 24 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 375,000
Exercise price: $19.36
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options reported herein were granted pursuant to the Issuer's 2022 Equity Incentive Plan. The grant was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated thereunder, having been approved by the Compensation Committee of the Issuer's Board of Directors. The options vest in equal quarterly installments over a three-year period from the grant date, in each case subject to the Reporting Person's continued employment with the Issuer or a subsidiary through the applicable vesting date.